Acadian Asset Management LLC Syros Pharmaceuticals, Inc. Transaction History

Acadian Asset Management LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$0.69 - $1.21 $37,663 - $66,047	54,585 Added 66.28%	136,939 $132,000
Q1 2022 May 12, 2022	BUY	$1.02 - $3.8 $84,001 - $312,945	82,354 New	82,354 $97,000
Q3 2021 Nov 12, 2021	SELL	$4.08 - $5.66 $1.45 Million - $2.01 Million	-354,453 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$5.01 - $7.48 $1.78 Million - $2.65 Million	354,453 New	354,453 $1.93 Million
Q1 2021 May 11, 2021	SELL	$7.19 - $14.95 $83,777 - $174,197	-11,652 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$6.66 - $14.66 $46,393 - $102,121	6,966 Added 148.66%	11,652 $126,000
Q3 2020 Nov 09, 2020	SELL	$8.69 - $14.47 $446,144 - $742,889	-51,340 Reduced 91.64%	4,686 $41,000
Q2 2020 Aug 12, 2020	BUY	$5.21 - $11.03 $291,895 - $617,966	56,026 New	56,026 $598,000
Q1 2020 May 11, 2020	SELL	$4.46 - $9.2 $117,766 - $242,925	-26,405 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$4.52 - $10.1 $119,350 - $266,690	26,405 New	26,405 $182,000
Q2 2019 Aug 08, 2019	SELL	$5.5 - $9.75 $59,334 - $105,183	-10,788 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$5.51 - $9.59 $59,441 - $103,456	10,788 New	10,788 $99,000
Q4 2018 Feb 07, 2019	SELL	$5.55 - $11.34 $30,697 - $62,721	-5,531 Closed	0 $0
Q3 2018 Oct 30, 2018	SELL	$9.74 - $12.92 $221,117 - $293,309	-22,702 Reduced 80.41%	5,531 $66,000
Q2 2018 Jul 24, 2018	BUY	$10.16 - $13.65 $282,854 - $380,016	27,840 Added 7083.97%	28,233 $288,000
Q1 2018 Apr 12, 2018	BUY	$9.47 - $12.98 $3,721 - $5,101	393 New	393 $5,000

Ticker SYRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,236,200
Market Cap $43.1M
Description
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are Tamibarotene, a selective retinoic acid receptor alpha agonist, which is in Phase III clinical trial for genomically def...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.